CD4 and cancer: In the OUTDO cohort, the percentages of CD4+ T and FOXP3+ T cells in cancerous tissues (Ca) and cancer stroma (STM) and their ratios (Ca/STM) did not show any statistically significant relationship with OS (Figure 2—figure supplement 1E).